MedPath

Intraoperative EABR for Decision Making

Recruiting
Conditions
Hearing Loss
Vestibular Schwannoma
Registration Number
NCT03745560
Lead Sponsor
Christoph Arnoldner
Brief Summary

In this study patients undergoing simultaneous translabyrinthine vestibular schwannoma resection and cochlear implantation are included. The goal of the study is to correlate the eABR results with postoperative hearing results.

Detailed Description

Patients undergoing translabyrinthine vestibular schwannoma resection are included in the study. Preoperatively an eABR is carried out, as well as before and after tumor resection.

Postoperatively patients are fitted with a cochlear implant as routinely carried out. The postoperative hearing results with cochlear implant are correlated to the eABR results. The study is an observational study since eABR measurements are not part of the study. A correlation between eABR results categorized in three groups (good response, weak response, no response) with monosyllable understanding with cochlear implant (measured with Freiburger monosyllables test).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients between 18 and 99 years undergoing translabyrinthine vestibular schwannoma resection
  • Patients wanted hearing rehabilitation with a cochlear implant
Exclusion Criteria
  • patients who do not want to be part of the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of eABR results to postoperative hearing results2 years

eABR is correlated with postoperative hearing results eABR will be divided in three categories - good response, weak response, no response.

Hearing results will be measured with speech understanding in Freiburg monosyllables word test which is measured in % of monosyllables understanding at 65 and 80dB

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AKH, MUW

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath